Gene · 23569
Papers4,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neutrophil extracellular traps in ischemic stroke: mechanisms, clinical implications, and therapeutic potential. | Front Neurol | 2025 | 41018178 | PubTator, text mining | PubMed |
| "Impact of peptidylarginine deiminase 4 (PAD4) deficiency in a fecal-induced peritonitis model of sepsis": comment. | J Thromb Haemost | 2025 | 41015511 | PubTator, text mining | PubMed |
| Deciphering the Structural Biology of GFAP: Connotations of Its Potency in Presaging the Diagnosis for Traumatic Brain Injury and AD. | Neurol Int | 2025 | 41002922 | PubTator, text mining | PubMed |
| The Skin Barrier: A System Driven by Phase Separation. | Cells | 2025 | 41002404 | PubTator, text mining | PubMed |
| Exploration of potential novel drug targets for rheumatoid arthritis by plasma proteome screening. | PLoS Comput Biol | 2025 | 40996951 | PubTator, text mining | PubMed |
| Isoform-Selective PAD2/PAD4 Substrates with Unnatural Amino Acids Enable Cellular Peptidylarginine Deiminase Activity Profiling and Reveal Vimentin Citrullination Effects in Macrophages. | Biochemistry | 2025 | 40994104 | PubTator, text mining | PubMed |
| A single oral administration of resveratrol cocrystals enables potent antisepsis therapy via interfering neutrophil extracellular traps formation. | Int J Pharm X | 2025 | 40989795 | PubTator, text mining | PubMed |
| Associations of PTPN22 and PADI4 polymorphisms with rheumatoid arthritis in ASWAN. | BMC Rheumatol | 2025 | 40983977 | PubTator, text mining | PubMed |
| Innate Immune Surveillance and Recognition of Epigenetic Marks. | Epigenomes | 2025 | 40981069 | PubTator, text mining | PubMed |
| Hemodiafiltration Attenuates NETosis Compared With High-Flux Hemodialysis in End-Stage Kidney Disease Patients. | Kidney Int Rep | 2025 | 40980683 | PubTator, text mining | PubMed |
| Neutrophil Extracellular Traps and Delayed Cerebral Ischemia in Patients With Subarachnoid Hemorrhage. | J Am Heart Assoc | 2025 | 40970545 | PubTator, text mining | PubMed |
| Citrullinated peptides of peptidyl arginine deiminase 4 as major B-cell epitopes in patients with rheumatoid arthritis. | Front Immunol | 2025 | 40963629 | PubTator, text mining | PubMed |
| Significance of neutrophil extracellular traps and low-density granulocytes in advanced chronic kidney disease (stage 5D) cases with COVID-19. | Ren Fail | 2025 | 40948469 | PubTator, text mining | PubMed |
| High Dose of Antithrombin Suppresses Neutrophil Extracellular Trap Formation in Human Neutrophils In Vitro Following Lipopolysaccharide- and Platelet-Induced Stimulation. | Surg Infect (Larchmt) | 2025 | 40948022 | PubTator, text mining | PubMed |
| The citrullinating enzyme PADI4 governs progenitor cell proliferation and translation in developing hair follicles. | Sci Adv | 2025 | 40938992 | PubTator, text mining | PubMed |
| Neutrophils in Myocarditis: A Focus on the Secretory and Phagocytotic Functions. | Rev Cardiovasc Med | 2025 | 40927089 | PubTator, text mining | PubMed |
| Repurposing zafirlukast confers renal protection in ischemia-reperfusion injury via suppressing macrophage METosis. | Int Immunopharmacol | 2025 | 40925201 | PubTator, text mining | PubMed |
| Astragaloside IV regulates the IRF7/NLRP3 axis to inhibit neutrophil extracellular trap formation and alleviate coxsackievirus B3-induced myocarditis. | Biochem Biophys Res Commun | 2025 | 40916305 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps in sepsis: trade-off between pros and cons. | Burns Trauma | 2025 | 40904580 | PubTator, text mining | PubMed |
| Emerging molecular targets in deep vein thrombosis: from inflammation to coagulation. | Hematology | 2025 | 40898418 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23569/papers?page=14